Clinical Trial Update: Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of a modified FOLFIRINOX regimen in advanced pancreatic cancer has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Modified FOLFIRINOX (modified FOLFIRINOX)

Snippet

Sponsor: Yale University | Conditions: Metastatic Pancreatic Cancer, Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-08-30